Management of asthma and allergic diseases during the coronavirus disease 2019 pandemic in India
Coronavirus disease 2019 (COVID 19) is caused by the novel coronavirus, which has affected 184 countries and the WHO has declared it a pandemic on March 2020. Allergic diseases such as allergic rhinitis and asthma are exaggerated by viral infections. Symptoms of allergic diseases overlap with COVID...
Main Authors: | Nagaraju Kuravi, Karthik Nagaraju, Venkata Kasyapi Voorakaranam |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2020-01-01
|
Series: | Indian Journal of Allergy Asthma and Immunology |
Subjects: | |
Online Access: | http://www.ijaai.in/article.asp?issn=0972-6691;year=2020;volume=34;issue=1;spage=15;epage=22;aulast=Kuravi |
Similar Items
-
Current issues on sublingual allergen-specific immunotherapy in children with asthma and allergic rhinitis
by: Živković Zorica, et al.
Published: (2016-01-01) -
The prevalence of respiratory allergens in patients with asthma and allergic rhinitis in Ardabil province
by: Rasool Molatefi, et al.
Published: (2020-10-01) -
Role of immunological mediators in the follow-up of asthma and allergic rhinitis patients on allergen immunotherapy
by: Raj Kumar, et al.
Published: (2020-01-01) -
Dropouts From Sublingual Immunotherapy and the Transition to Subcutaneous Immunotherapy in House Dust Mite-Sensitized Allergic Rhinitis Patients
by: Huan Chen, et al.
Published: (2022-01-01) -
Stepwise approach towards adoption of allergen immunotherapy for allergic rhinitis and asthma patients in daily practice in Belgium: a BelSACI-Abeforcal-EUFOREA statement
by: P. W. Hellings, et al.
Published: (2019-02-01)